# Lessons From the Edge of Reactivation: Managing Herpes Simplex Virus Encephalitis Years After Initial Infection in High-Risk Neurosurgical Patients

**Authors:** Takashi Matsumori, Ichiro Takumi, Takashi Asahi, Kyoko Tatebayashi, Hidetoshi Murata

PMC · DOI: 10.7759/cureus.77883 · 2025-01-23

## TL;DR

This paper discusses the risks and management of herpes simplex virus reactivation in high-risk neurosurgical patients, emphasizing the need for proactive care.

## Contribution

The paper introduces a case study highlighting the critical risk of HSE reactivation in patients with a prior history of HSE.

## Key findings

- A nine-year-old girl with a history of HSE experienced reactivation after neurosurgery, leading to severe neurological issues.
- Perioperative steroid use and surgical stress were identified as contributing factors to HSE reactivation.
- Prophylactic antiviral therapy and early intervention are recommended for high-risk patients to prevent severe outcomes.

## Abstract

Herpes simplex encephalitis (HSE) is a severe central nervous system infection with significant morbidity and mortality. While rare, reactivation of HSE following neurosurgical procedures is increasingly reported, particularly in patients with a previously clinically significant HSE, which is the most critical risk factor for reactivation. This case highlights the challenges of managing HSE reactivation risk in pediatric patients with a history of HSE, who are considered high risk due to their susceptibility to viral reactivation. As demonstrated in a nine-year-old girl with intractable epilepsy who underwent corpus callosotomy, postoperative day seven was marked by fever, altered consciousness, and seizures. Delayed antiviral therapy led to severe neurological sequelae. Identified risk factors included perioperative steroid use and surgical stress, with the history of HSE standing out as the predominant risk factor. This case underscores the importance of defining high-risk groups, specifically patients with a prior history of HSE, and proactively managing their care, including consideration of prophylactic antiviral therapy. Early recognition, timely intervention, and comprehensive perioperative strategies are essential to mitigating the risk of severe outcomes in this vulnerable population.

## Linked entities

- **Diseases:** Herpes simplex encephalitis (MONDO:0012521)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** HSE (MESH:D020803), Encephalitis (MESH:D004660), neurological sequelae (MESH:D009422), central nervous system infection (MESH:D002494), fever (MESH:D005334), altered consciousness (MESH:D003244), seizures (MESH:D012640), Infection (MESH:D007239), epilepsy (MESH:D004827)
- **Chemicals:** steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11847158/full.md

---
Source: https://tomesphere.com/paper/PMC11847158